Oncology & Cancer

Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma

Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients' T cells so they can better find and destroy tumor cells. But CAR-T cell therapy doesn't work well in every cancer—including ...

Health

Canada unveils framework for universal drug plan

Canada on Thursday unveiled a framework for a universal drug plan that, once fully implemented, would mark the biggest expansion of its publicly funded health care system in decades.

Addiction

Q&A: How war worsened the opioid crisis in Ukraine

Medications to treat opioid use disorder, including methadone and buprenorphine, have been shown to save lives, cutting overdose deaths by up to 60% and reducing the transmission of HIV by offering a safe alternative to injection ...

Diseases, Conditions, Syndromes

Sickle cell and COVID-19: A risky mix of two diseases

UdeM's Stéphanie Forté and co-researchers in Canada and Brazil have shown how people with sickle cell disease or sickle cell trait have a higher chance of dying from COVID-19 than the general population.

page 14 from 40